DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $56,000 | -18.8% | 43,447 | +0.5% | 0.00% | – |
| Q4 2016 | $69,000 | -88.9% | 43,219 | +0.4% | 0.00% | – |
| Q3 2016 | $624,000 | +90.2% | 43,067 | +29.8% | 0.00% | – |
| Q2 2016 | $328,000 | +4.1% | 33,170 | 0.0% | 0.00% | – |
| Q1 2016 | $315,000 | -7.4% | 33,170 | +9.1% | 0.00% | – |
| Q4 2015 | $340,000 | -19.8% | 30,411 | +0.3% | 0.00% | – |
| Q3 2015 | $424,000 | +207.2% | 30,335 | +178.3% | 0.00% | – |
| Q2 2015 | $138,000 | -6.8% | 10,901 | 0.0% | 0.00% | – |
| Q1 2015 | $148,000 | +19.4% | 10,901 | 0.0% | 0.00% | – |
| Q4 2014 | $124,000 | +14.8% | 10,901 | 0.0% | 0.00% | – |
| Q3 2014 | $108,000 | – | 10,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 194,340 | $253,000 | 0.02% |
| MIDDLETON & CO INC/MA | 15,848 | $21,000 | 0.01% |
| Acrospire Investment Management LLC | 4,220 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,942 | $26,000 | 0.00% |
| A.R.T. Advisors, LLC | 32,426 | $42,000 | 0.00% |
| FNY Partners Fund LP | 500 | $5,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 43,447 | $56,000 | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 13,200 | $17,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 24,378 | $32,000 | 0.00% |
| MORGAN STANLEY | 7,566 | $10,000 | 0.00% |